tirzepatide and semaglutide peptide or small molecule Ozempic® (semaglutide) Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Tirzepatide Research: Comprehensive Review of

Gut 66 , 17391747 (2017)

[] As reported by Min and Bain [] tirzepatide treatment shows a potent glucose-lowering effect and promotes weight loss with minimum GI adverse effects in the animal study as well as phase I and II human trials, in comparison with established GLP-1RA

KLOW

Due to its sizable patient population with obesity and associated disorders such as type 2 diabetes and cardiovascular diseases, the United States in particular holds a significant portion of the market

Dysbiosis may affect neurotransmitter production since gut bacteria synthesize significant amounts of serotonin and other signaling molecules